The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

Exagen (XGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

Xiao Ting, a director at Zenas BioPharma, Inc. (NASDAQ:ZBIO), has acquired 10,000 shares of the company's common stock, according to a recent filing with the Securities and Exchange Commission. The ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Lockheed Martin has achieved a milestone for its solution for the USSF Space Systems Command's MUOS Service Life Extension ...

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly grow ...

Mass General Brigham researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery ...

Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...